Cubist Systematic Strategies, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$728,792
+769.1%
398,247
+488.9%
0.00%
+300.0%
Q4 2023$83,857
+1193.9%
67,627
+502.1%
0.00%
Q4 2022$6,481
+8.0%
11,232
-38.6%
0.00%
Q2 2022$6,000
-98.3%
18,295
-88.5%
0.00%
-100.0%
Q4 2021$358,000
+109.4%
158,507
+167.4%
0.00%
+50.0%
Q3 2021$171,000
-63.8%
59,280
-52.4%
0.00%
-60.0%
Q2 2021$472,000
+136.0%
124,475
+110.8%
0.01%
+66.7%
Q1 2021$200,000
+185.7%
59,060
+137.0%
0.00%
+200.0%
Q4 2020$70,000
-15.7%
24,917
-25.1%
0.00%0.0%
Q3 2020$83,000
-93.4%
33,259
-64.1%
0.00%
-95.5%
Q2 2020$1,259,000
+135.3%
92,700
+31.3%
0.02%
+57.1%
Q1 2020$535,000
+63.1%
70,606
+36.2%
0.01%
+133.3%
Q4 2019$328,000
+11.2%
51,835
-15.0%
0.01%
+20.0%
Q2 2019$295,000
-47.8%
61,000
-11.6%
0.01%
-72.2%
Q1 2019$565,000
+91.5%
69,010
+29.3%
0.02%
+28.6%
Q4 2018$295,000
+2007.1%
53,384
+3391.4%
0.01%
+1300.0%
Q3 2018$14,000
-89.8%
1,529
-88.9%
0.00%
-85.7%
Q2 2018$137,000
-13.3%
13,733
-17.2%
0.01%
-22.2%
Q1 2018$158,000
-0.6%
16,586
+50.3%
0.01%
-10.0%
Q2 2017$159,000
+3080.0%
11,038
+1490.5%
0.01%
Q2 2016$5,000
-78.3%
694
-73.4%
0.00%
-100.0%
Q1 2016$23,000
-93.5%
2,605
-90.5%
0.00%
-95.2%
Q4 2015$356,00027,5210.02%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,121,283$53,979,0004.02%
DAFNA Capital Management LLC 853,538$6,470,0002.70%
Baupost Group 17,527,968$132,862,0001.96%
Nantahala Capital Management 6,559,478$49,721,0001.86%
Novo Holdings A/S 3,393,039$25,719,0001.72%
Abrams Capital Management 5,656,462$42,876,0001.69%
Stanley-Laman Group, Ltd. 319,073$2,419,0000.73%
Integral Health Asset Management, LLC 200,000$1,516,0000.67%
KNOTT DAVID M 135,169$1,025,0000.65%
Leap Investments LP 54,700$415,0000.61%
View complete list of AKEBIA THERAPEUTICS INC shareholders